Eupraxia Pharmaceuticals Reports Additional 52-week Follow-up Data from the RESOLVE Trial in Eosinophilic Esophagitis (EoE) Demonstrating Consistent Results af…

The 52-week symptom data reported for Cohort 6 patients is consistent with the long-term durability data previously reported ...

Heidelberger Druckmaschinen Aktiengesellschaft (HBGRY) Q2 2026 Earnings Call Prepared Remarks Transcript

Heidelberger Druckmaschinen Aktiengesellschaft ( OTCPK:HBGRY) Q2 2026 Earnings Call November 12, 2025 8:00 AM EST Good afternoon, ladies and gentlemen, and welcome to the Heidelberger Druckmaschinen ...

Buckle: Strong Margins And Stable Balance Sheet, But Limited Future Catalysts

The Buckle, Inc. is rated a Hold with a price target of $55-$65, reflecting limited upside and a narrow margin of safety.

12 “thanks, Defense” graphs from the win over LSU

The Tide's efficiency metrics looked slightly better than the eye test, but defensive dominance sealed the win ...